{"id":"https://openalex.org/W7225614187","doi":"https://doi.org/10.64898/2026.11.06.764804","title":"Therapeutic anti-IgE antibodies generate distinct functional immune complex signatures","display_name":"Therapeutic anti-IgE antibodies generate distinct functional immune complex signatures","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225614187","doi":"https://doi.org/10.64898/2026.11.06.764804"},"language":"en","primary_location":{"id":"doi:10.64898/2026.11.06.764804","doi":"https://doi.org/10.64898/2026.11.06.764804","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.11.06.764804","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/11/09/2026.11.06.764804.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.biorxiv.org/content/biorxiv/early/2026/11/09/2026.11.06.764804.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160989825","display_name":"Mar\u00eda Mir\u00f3 Navarro","orcid":"https://orcid.org/0009-0001-7386-1771","observed_orcids":["https://orcid.org/0009-0001-7386-1771"]},"institutions":[{"id":"https://openalex.org/I118564535","display_name":"University of Bern","ror":"https://ror.org/02k7v4d05","country_code":"CH","type":"education","lineage":["https://openalex.org/I118564535"]},{"id":"https://openalex.org/I2801112126","display_name":"University Hospital of Bern","ror":"https://ror.org/01q9sj412","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2801112126"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Maria Miro Navarro","raw_affiliation_strings":["Inselspital Bern, University of Bern;"],"raw_orcid":"https://orcid.org/0009-0001-7386-1771","affiliations":[{"raw_affiliation_string":"Inselspital Bern, University of Bern;","institution_ids":["https://openalex.org/I118564535","https://openalex.org/I2801112126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088124474","display_name":"Alexander Gregor Geiger","orcid":"https://orcid.org/0000-0002-1372-1929","observed_orcids":["https://orcid.org/0000-0002-1372-1929"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander Gregor Geiger","raw_affiliation_strings":["Lino Biotech"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lino Biotech","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046729215","display_name":"Simona Notov\u00e1","orcid":"https://orcid.org/0000-0003-3728-2948","observed_orcids":["https://orcid.org/0000-0003-3728-2948"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simona Notova","raw_affiliation_strings":["Lino Biotech"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lino Biotech","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020864682","display_name":"Andreas Frutiger","orcid":"https://orcid.org/0000-0002-2523-8918","observed_orcids":["https://orcid.org/0000-0002-2523-8918"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas Frutiger","raw_affiliation_strings":["Lino Biotech"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lino Biotech","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161052924","display_name":"Martin Fabian Bachmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118564535","display_name":"University of Bern","ror":"https://ror.org/02k7v4d05","country_code":"CH","type":"education","lineage":["https://openalex.org/I118564535"]},{"id":"https://openalex.org/I2801112126","display_name":"University Hospital of Bern","ror":"https://ror.org/01q9sj412","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2801112126"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Martin Fabian Bachmann","raw_affiliation_strings":["Inselspital Bern, University of Bern;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inselspital Bern, University of Bern;","institution_ids":["https://openalex.org/I118564535","https://openalex.org/I2801112126"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078796492","display_name":"Paul Engeroff","orcid":"https://orcid.org/0000-0002-3409-512X","observed_orcids":["https://orcid.org/0000-0002-3409-512X"]},"institutions":[{"id":"https://openalex.org/I118564535","display_name":"University of Bern","ror":"https://ror.org/02k7v4d05","country_code":"CH","type":"education","lineage":["https://openalex.org/I118564535"]},{"id":"https://openalex.org/I2801112126","display_name":"University Hospital of Bern","ror":"https://ror.org/01q9sj412","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2801112126"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Paul Engeroff","raw_affiliation_strings":["Inselspital Bern, University of Bern;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inselspital Bern, University of Bern;","institution_ids":["https://openalex.org/I118564535","https://openalex.org/I2801112126"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5078796492"],"corresponding_institution_ids":["https://openalex.org/I118564535","https://openalex.org/I2801112126"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.012900000438094139,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-ige-antibody","display_name":"anti-IgE","score":0.8629999756813049},{"id":"https://openalex.org/keywords/omalizumab","display_name":"omalizumab","score":0.996999979019165},{"id":"https://openalex.org/keywords/ligelizumab","display_name":"ligelizumab","score":1.0},{"id":"https://openalex.org/keywords/immune-complexes","display_name":"immune complexes","score":0.8899999856948853},{"id":"https://openalex.org/keywords/fc-receptors","display_name":"Fc receptors","score":0.7419999837875366},{"id":"https://openalex.org/keywords/fc-gamma-receptor","display_name":"Fc gamma receptor","score":0.7369999885559082},{"id":"https://openalex.org/keywords/antibody-neutralization","display_name":"antibody neutralization","score":0.5709999799728394}],"concepts":[{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7214000225067139},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6563000082969666},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5148000121116638},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.511900007724762},{"id":"https://openalex.org/C2777066959","wikidata":"https://www.wikidata.org/wiki/Q869711","display_name":"Cricetulus","level":4,"score":0.43149998784065247},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.41600000858306885},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4097999930381775},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.387800008058548},{"id":"https://openalex.org/C2778474638","wikidata":"https://www.wikidata.org/wiki/Q575241","display_name":"Immune complex","level":3,"score":0.3813999891281128},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.3546000123023987},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3463999927043915},{"id":"https://openalex.org/C45121317","wikidata":"https://www.wikidata.org/wiki/Q4927287","display_name":"Blocking antibody","level":3,"score":0.33899998664855957},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.32839998602867126},{"id":"https://openalex.org/C2908797038","wikidata":"https://www.wikidata.org/wiki/Q575241","display_name":"Antigen-Antibody Complex","level":3,"score":0.31529998779296875},{"id":"https://openalex.org/C2778564945","wikidata":"https://www.wikidata.org/wiki/Q415392","display_name":"Omalizumab","level":4,"score":0.3068000078201294},{"id":"https://openalex.org/C3018913218","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody response","level":3,"score":0.29980000853538513},{"id":"https://openalex.org/C86756495","wikidata":"https://www.wikidata.org/wiki/Q7702931","display_name":"Ternary complex","level":3,"score":0.28540000319480896},{"id":"https://openalex.org/C167625842","wikidata":"https://www.wikidata.org/wiki/Q899763","display_name":"Peptide sequence","level":3,"score":0.2809000015258789},{"id":"https://openalex.org/C3018252375","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune recognition","level":3,"score":0.2712000012397766},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.26510000228881836},{"id":"https://openalex.org/C2780898057","wikidata":"https://www.wikidata.org/wiki/Q79448","display_name":"Immunoglobulin G","level":3,"score":0.25760000944137573},{"id":"https://openalex.org/C174510640","wikidata":"https://www.wikidata.org/wiki/Q489618","display_name":"HEK 293 cells","level":3,"score":0.2563000023365021},{"id":"https://openalex.org/C2780405999","wikidata":"https://www.wikidata.org/wiki/Q3483597","display_name":"Co-stimulation","level":5,"score":0.2549999952316284},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2531999945640564}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.11.06.764804","doi":"https://doi.org/10.64898/2026.11.06.764804","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.11.06.764804","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/11/09/2026.11.06.764804.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.11.06.764804","doi":"https://doi.org/10.64898/2026.11.06.764804","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.11.06.764804","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/11/09/2026.11.06.764804.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320310992","display_name":"University of Bern","ror":"https://ror.org/02k7v4d05"},{"id":"https://openalex.org/F4320311317","display_name":"Fondation Acteria","ror":"https://ror.org/029x73965"},{"id":"https://openalex.org/F4320318017","display_name":"Inselspital, Universit\u00e4tsspital Bern","ror":"https://ror.org/01q9sj412"},{"id":"https://openalex.org/F4320320924","display_name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","ror":"https://ror.org/00yjd3n13"},{"id":"https://openalex.org/F4320332736","display_name":"Novartis Pharma","ror":"https://ror.org/0013shd50"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225614187.pdf","grobid_xml":"https://content.openalex.org/works/W7225614187.grobid-xml"},"referenced_works_count":1,"referenced_works":["https://openalex.org/W2969582750"],"related_works":["https://openalex.org/W2999840425","https://openalex.org/W2609560535","https://openalex.org/W3006039641","https://openalex.org/W1991700932","https://openalex.org/W4205402280","https://openalex.org/W4313354746","https://openalex.org/W2268022034","https://openalex.org/W2074220006","https://openalex.org/W1228545609","https://openalex.org/W2019930990"],"abstract_inverted_index":{"Therapeutic":[0],"IgG":[1],"anti-IgE":[2],"antibodies":[3,96],"are":[4],"benchmarked":[5],"by":[6],"their":[7,15],"ability":[8,92],"to":[9,97],"interfere":[10],"with":[11,41],"IgE-Fc[epsilon]RI":[12,99],"binding,":[13],"but":[14],"activity":[16],"within":[17],"IgE":[18],"and":[19,31,36,53,59,72,76,83,101],"IgG-containing":[20],"immune":[21,39],"complexes":[22,40,50],"remains":[23],"poorly":[24],"defined.":[25],"Here":[26],"we":[27,65],"show":[28],"that":[29],"omalizumab":[30],"ligelizumab":[32],"form":[33],"binary":[34],"IgE-IgG":[35],"ternary":[37],"allergen-containing":[38],"distinct":[42,78],"functional":[43],"properties.":[44],"In":[45],"primary":[46],"human":[47],"leukocytes,":[48],"these":[49],"exhibited":[51],"antibody-":[52],"composition-dependent":[54],"patterns":[55],"of":[56,93,111],"cellular":[57],"association":[58],"activation.":[60],"Using":[61],"multiplexed":[62],"focal":[63],"molography,":[64],"resolved":[66],"Fc":[67],"receptor":[68],"engagement":[69],"across":[70],"free":[71],"complexed":[73],"antibody":[74,113],"states":[75],"identified":[77],"receptor-binding":[79],"signatures":[80],"for":[81],"omalizumab-":[82],"ligelizumab-containing":[84],"complexes.":[85],"Notably,":[86],"allergen":[87],"incorporation":[88],"reversed":[89],"the":[90,94],"relative":[91],"two":[95],"neutralize":[98],"interactions":[100],"remodelled":[102],"Fc[gamma]R":[103],"binding.":[104],"Thus,":[105],"immune-complex":[106],"composition":[107],"is":[108],"a":[109],"determinant":[110],"therapeutic":[112],"function.":[114]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}
